tert-Butyl 4-hydroxyazepane-1-carboxylate

Catalog No. :
ACASCR518
CAS No. :
478832-21-2
Molecular Formula :
C11H21NO3
Molecular Weight :
215.29

IUPAC Name:tert-butyl 4-hydroxyazepane-1-carboxylate

tert-Butyl 4-hydroxyazepane-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$68.00Login to see priceIn stockIn stock
25g97%$284.00Login to see priceIn stockIn stock
100g97%$861.00Login to see priceIn stockIn stock
500g97%$3443.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-hydroxyazepane-1-carboxylate
IUPAC Nametert-butyl 4-hydroxyazepane-1-carboxylate
MDL No.MFCD07368610
Molecular FormulaC11H21NO3
Molecular Weight215.29
SMILESC(C)(C)(C)OC(=O)N1CCCC(CC1)O
InChI KeyCRFSWDBNKHNGGA-UHFFFAOYSA-N
SynonymEN300-154246 | SCHEMBL1096914 | A7310 | n-boc-4-hydroxyazepane | 4-Hydroxy-azepane-1-carboxylic acid tert-butyl ester | 4-HYDROXYAZEPANE-1-CARBOXYLIC ACID TERT-BUTYL ESTER | 4-Hydroxyazepane-1-carboxylicacidtert-butylester | CS-D0037 | J-524710 | SCHEMBL2
CAS No.478832-21-2
PubChem CID22933363

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACASCR518 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZXMC820 route compound structure diagram
    ACZXMC820188975-88-4 In Stock
  2. Then
  3. ACASCR518 route product structure diagram
    ACASCR518478832-21-2 In Stock
Inquiry

2. ACASCR518 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPHXA463 route compound structure diagram
    ACPHXA4631159823-34-3 In Stock
  4. Then
  5. ACASCR518 route product structure diagram
    ACASCR518478832-21-2 In Stock
Inquiry

Comments (0)